Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

dynamo76again 1 post  |  Last Activity: Dec 16, 2015 1:03 PM Member since: Sep 11, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • 88 % of respondents ( doctors ) believe Pimavanserin is safer than atypical antipsychotics in PDP, with half of docs viewing Pima's safety profile as 'SUPERIOR'.
    0% of docs view Pimavanserin's safety as worse than antipsychotics.
    Given the level of unmet need, most plans to use drug of-label in AD/psychotic dementia once it is approved in Parkinson's.

    Sentiment: Buy